Showing results (1941-1950 of 6,689) with videos related to

Sort By:
Pageof 669
Neurobiology of Disease|October 18, 2020
The relation between tau pathology and granulovacuolar degeneration of neuronsBehrus Puladi, Maja Dinekov, Thomas Arzberger, et al.
Neurobiology of Disease|January 9, 2020
The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's diseasePascaline Aimé, Saravanan S Karuppagounder, Apeksha Rao, et al.
Neurobiology of Disease|November 24, 2019
Synaptic zinc contributes to motor and cognitive deficits in 6-hydroxydopamine mouse models of Parkinson's diseaseJoanna Sikora, Brigitte L Kieffer, Pierre Paoletti, et al.
Neurobiology of Disease|December 2, 2019
NMDA receptors on parvalbumin-positive interneurons and pyramidal neurons both contribute to MK-801 induced gamma oscillatory disturbances: Complex relationships with behaviourMatthew R Hudson, Elysia Sokolenko, Terence J O'Brien, et al.
Neurobiology of Disease|January 22, 2019
Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse modelAntoine Leboucher, Tariq Ahmed, Emilie Caron, et al.
Neurobiology of Disease|January 25, 2019
The role of pallidum in the neural integrator model of cervical dystoniaAlexey Sedov, Svetlana Usova, Ulia Semenova, et al.
Neurobiology of Disease|February 10, 2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's diseaseNidhi Sharma, Antonella Tramutola, Chiara Lanzillotta, et al.
Neurobiology of Disease|February 12, 2019
GABAA receptor-mediated networks during focal seizure onset and progression in vitroMarco de Curtis, Laura Librizzi, Laura Uva, et al.
Neurobiology of Disease|January 6, 2019
Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?Matthew J Sharman, Erika Gyengesi, Huazheng Liang, et al.
Neurobiology of Disease|November 10, 2020
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich AtaxiaLaura Rodríguez-Pascau, Elena Britti, Pablo Calap-Quintana, et al.
Pageof 669